Navigation Links
New Therapy Freezes Out Esophageal Cancers
Date:8/9/2008

Cryoablation attractive option for older patients with other medical issues, team says

FRIDAY, Aug. 8 (HealthDay News) -- A new method of freezing damaged cells in the esophagus to prevent them from turning cancerous is being used by gastroenterologists at the University of Texas Southwestern Medical Center at Dallas.

A condition called Barrett's esophagus can result from ongoing heartburn, in which stomach acid constantly splashes into the esophagus. Untreated, this can become Barrett's with dysplasia, in which cells start to transform.

"Due to damage from chronic stomach acid, they are people who have a higher risk of developing esophagus cancer. The goal of this therapy is to literally freeze the damage in its tracks and stop it before it turns to cancer," Dr. Jayaprakash Sreenarasimhaiah, an assistant professor of internal medicine in the division of digestive and liver diseases, said in a UT Southwestern news release.

In this U.S. Food and Drug Administration-approved treatment, a special catheter is used to spray liquid nitrogen on the damaged tissue to freeze the lining of the esophagus. The treated tissue falls away, allowing normal cells to grow and replace the damaged cells in about six to eight weeks.

Patients are sedated for the cryoablation therapy, which takes about 30 to 40 minutes.

Typical treatment for Barrett's esophagus with dysplasia has included mucosal resection, in which the damaged lining is scraped away. This procedure can take hours and cause side effects such as bleeding or narrowing of the esophagus. In some cases, patients have surgery to remove the damaged sections of the esophagus. However, some patients are too sick or elderly for surgery while others want another option.

"This is a disease we see in a lot of older patients with other illnesses, so the decision to send them to surgery requires careful consideration. Cryoablation therapy is particularly
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Targeted drug therapy found effective in patients with common form of immune-mediated kidney disease
2. Overcoming inhibitors of cell death improves cancer therapy efficacy
3. Sweden to Receive Scandinavia's First TomoTherapy System : Lund University Hospital to Offer Swedish Cancer Patients the Most Advanced Image-Guided Radiation Therapy Treatments
4. New treatment therapy helps inhibit hepatitis C
5. Antiviral therapy helps children at risk for post-transplant lymphoproliferative disease
6. BrainLAB Announces 510(k) FDA Clearance of Monte Carlo Dose Engine for Stereotactic Radiosurgery and Radiation Therapy
7. New therapy for HIV treatment
8. Gentiva Safe Strides(R) Home Balance Therapy Program is Reducing Risk of Dangerous Falls and Relieving Pain for Thousands of Older Americans
9. Erectile dysfunction drugs allowed more chemotherapy to reach brain tumors in laboratory study
10. CSHL scientists correlate enzyme expression levels with chemotherapy drug response
11. D-cycloserine may improve behavioral therapy treatment for anxiety
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/26/2014)... 2014 Parker & Sons, Inc. ... in heating, cooling and plumbing contractor services throughout ... services in 2014 with regard to air-conditioning systems. ... is known for its incredibly hot summers. Working ... intricacies and details of a wide variety of ...
(Date:12/25/2014)... 2014 The click strand ... strength and durability. Today, the business announces a ... valid until Jan. 30, 2015. , Click strand ... hardwood. BambooFlooringChina.com is a well-known brand in the ... to find a reliable bamboo flooring supplier. , ...
(Date:12/25/2014)... 2014 Product liability lawsuits filed in ... ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward in federal ... issued in the U.S. District Court, Northern District of ... open conference on January 7, 2015, at the Paul ... West Palm Beach, Florida. The Conference is scheduled to ...
(Date:12/25/2014)... Recently, Dylan Queen, a famous online company supplying ... of discounted prom dresses, most of which are priced ... the company, the promotion is valid until Jan. 22, ... the UK market. , The prom dresses in this ... styles: A-line strapless, empire strapless chiffon, one shoulder, floor-length, ...
(Date:12/25/2014)... sells many bamboo products and the business is famous ... announces big discounts on its bamboo mats , which ... the world’s leader in bamboo flooring. According to the ... 2015. , The bamboo mats are made from well-treated ... the bamboo strips for the mats are boiled and ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2
... , PHILADELPHIA, June 19 Kensey Nash Corporation (Nasdaq: ... and President, received the Ernst & Young Entrepreneur Of The ... in the greater Philadelphia region. According to Ernst & ... and leading dynamic, growing businesses. Joe Kaufmann was selected ...
... cases of E. coli infection in 28 states ... are warning consumers not to eat any Nestlé Toll House ... E. coli contamination. , In response to the Food ... was voluntarily recalling its Toll House refrigerated cookie dough items. ...
... ... which provides an invaluable service to many patients who need blood products. , ... Washington (Vocus) June 19, 2009 -- Children,s ... which provides an invaluable service to many patients who need blood products. Children,s National is ...
... levels in patients , FRIDAY, June 19 (HealthDay News) ... may explain brain gray matter reductions experienced by patients ... found an association between fibromyalgia and reductions in gray ... , In this new study, Dr. Patrick B. Wood, ...
... ARDEE, Ireland, June 19 Warner Chilcott Limited (Nasdaq: ... Wachovia,s 19th Annual Mid-Year Equity Conference on Wednesday, June 24, ... will be Rochelle Fuhrmann, Senior Director, Investor Relations. , ... interested parties at www.wcrx.com under the Investor Relations ...
... ... Control Spread of Infectious Diseases , ... Fargo, ND (PRWEB) June 19, 2009 - Last week, the World Health Organization declared ... state health officials in the U.S. are urging healthcare providers to take precautions to limit ...
Cached Medicine News:Health News:Kensey Nash Corporation's CEO & President, Joe Kaufmann Named Ernst & Young Entrepreneur Of The Year(R) 2009 Award Winner in Greater Philadelphia Region 2Health News:Kensey Nash Corporation's CEO & President, Joe Kaufmann Named Ernst & Young Entrepreneur Of The Year(R) 2009 Award Winner in Greater Philadelphia Region 3Health News:Nestlé Recalls Cookie Dough Products 2Health News:Children's National Medical Center Dedicates New Blood Donor Center 2Health News:Children's National Medical Center Dedicates New Blood Donor Center 3Health News:Real-Time Locating Technology Helps Contain Pandemic Outbreaks 2Health News:Real-Time Locating Technology Helps Contain Pandemic Outbreaks 3Health News:Real-Time Locating Technology Helps Contain Pandemic Outbreaks 4
(Date:12/24/2014)... Dec. 24, 2014  Actavis plc (NYSE: ... has received a complete response letter from the ... New Drug Application (NDA) for the fixed-dose combination ... of hypertension.   Photo - http://photos.prnewswire.com/prnh/20130124/NY47381LOGO ... in the receipt of a complete response letter, ...
(Date:12/24/2014)... Tianyin Pharmaceutical Inc. (NYSE Amex: TPI ... patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded ... preliminary financial results for the first quarter of ... Ended September 30, 2014 Financial Highlights: , ... in 1Q14 with gross margins improved to 52% ...
(Date:12/24/2014)... N.J. , Dec. 24, 2014 ... a late-stage biopharmaceutical company developing products that address ... oncology and biodefense, announced today that on December ... public offering. The Company raised approximately ... and intends to use the net proceeds from ...
Breaking Medicine Technology:Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 2Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 3Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 2TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 3TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 5TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 6TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 7TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 8TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 9TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 10TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 11TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 12Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3
... Avaulta™ BioSynthetic Mesh ... mesh coated in the ... absorbable, hydrophilic film of ... segments of the Avaulta™ ...
The Repliform Tissue Regeneration Matrix is an acellular human dermal allograft that when surgically implanted is intended to function as a template, facilitating the body's fibroblasts to regenerate...
... Pelvicol® Acellular Collagen Matrix delivers the ... exceptional strength, versatility, and durability in ... the effectiveness of site-specific defect repair ... sterile, biocompatible, crosslinked porcine dermal collagen ...
... The QIAamp Viral RNA ... viral nucleic acids from cell-free ... nucleic acids that can be ... but are not limited to, ...
Medicine Products: